National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 10/8/2021 release of VAERS data:

This is VAERS ID 1086803

Case Details

VAERS ID: 1086803 (history)  
Form: Version 2.0  
Sex: Male  
Location: Foreign  
Submitted: 0000-00-00
Entered: 2021-03-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Kidney transplant
Diagnostic Lab Data:
CDC Split Type: ILPFIZER INC2021240115

Write-up: got sick with Corona ,one of them also died; got sick with Corona ,one of them also died; This is a spontaneous report from a contactable physician. The physician reported same event for four patients, this is the first of four reports. A male patient of an unspecified age received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date at SINGLE DOSE of first dose, via an unspecified route of administration on an unspecified date at SINGLE DOSE of second dose for covid-19 immunisation. Medical history included kidney transplant. The patient''s concomitant medications were not reported. The patient received 2 doses of BNT162b2 and got sick with Corona and died. The patient died on an unspecified date. It was not reported if an autopsy was performed. Information about Batch/Lot number has been requested.; Sender''s Comments: Based on the limited information provided, the Company (Pfizer) cannot exclude that the suspect medication may have contributed to the reported events in this patient. Additional information regarding onset dates of drug administration/ events and concomitant medications will aid in comprehensive assessment of the case. The impact of this report on the benefit-risk profile of the Pfizer product and on the conduct of the study is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, ethics committees. and investigators, as appropriate.,Linked Report(s) : IL-PFIZER INC-2021240116 same drug/event in different patients;IL-PFIZER INC-2021240117 same drug/event in different patients;IL-PFIZER INC-2021240118 same drug/event in different patients; Reported Cause(s) of Death: got sick with Corona ,one of them also died; got sick with Corona ,one of them also died

New Search

Link To This Search Result:

Government Disclaimer on use of this data

Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166